Klotho shares have soared more than 1000% over the past three months on promising results and breakthrough hopes.

Klotho Neurosciences ( ($KLTO) ) has provided an announcement. On July 10, 2025, Klotho Neurosciences announced that the FDA granted Orphan Drug ...

The FDA’s Orphan Drug Designation offers incentives like seven years of U.S. market exclusivity, tax credits for clinical ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

Investing.com -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) stock surged 22% after the company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its ...

Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading ...

Boosting Klotho protein levels in mice improves physical and cognitive aging, offering potential for future longevity ...

Get today's Klotho Neuroscience stock news. We cover the latest Klotho Neuroscience headlines and breaking news impacting Klotho Neuroscience stock performance.

Check out our KLTO stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.

Review the current Klotho Neurosciences Inc (KLTO:XNAS) dividend yield and history to decide if KLTO is the best investment for you.